CRBU
Caribou Biosciences Inc
NASDAQ: CRBU · HEALTHCARE · BIOTECHNOLOGY
$1.88
-2.08% today
Updated 2026-04-30
Market cap
$205.84M
P/E ratio
—
P/S ratio
18.45x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$1 – $4
Volume
1.4M
Caribou Biosciences Inc (CRBU) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-32.01M | $-33.22M | $-32.52M | $-90.97M | $-93.29M | $-138.20M | $-110.99M |
| Capital expenditures | $884000.00 | $1.31M | $3.12M | $6.45M | $11.61M | $6.50M | $1.36M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $1.23M | $1.00M | $3.45M | $11.72M | $13.75M | $16.71M | $12.68M |
| Free cash flow | $-32.89M | $-34.53M | $-35.64M | $-97.42M | $-104.90M | $-144.71M | $-112.35M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $224.51M | $-182.08M | — | — | — |